Fabien Mselati: Reflecting on 25 Years of Hemophilia Progress
Fabien Mselati, Vice President of Rare Diseases at Novo Nordisk France, shared a post on LinkedIn:
“From one Paris Congress to another: 25 years of commitment to haemophilia.
In July 2001, the previous ISTH Congress held in Paris coincided with the beginning of my journey in haemophilia.
Returning to Paris for International Society on Thrombosis and Hemostasis (ISTH) 2026, has been a powerful full-circle moment.
Over these 25 years, haemophilia care has changed profoundly.
Protection has become more effective and longer lasting.
New therapeutic approaches have broadened choice, care has become more personalized, and joint health, quality of life and individual aspirations have moved closer to the center of care.
Yet progress has not eliminated compromise.
People living with haemophilia still balance protection, treatment burden and the freedom to live life on their own terms.
Our responsibility is to keep listening and turn scientific advances into meaningful solutions that offer greater choice.
The richest part of these 25 years has been the people.
I have had the privilege of meeting extraordinary individuals from every background and every part of the world: people living with haemophilia and their families, patient advocates, physicians, nurses, researchers, and colleagues.
Their courage, expertise, generosity and determination have shaped my perspective and strengthened my commitment.
Paris 2001 marked a beginning.
Paris 2026 is a moment to look back with gratitude, and forward with renewed purpose.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment